Literature DB >> 23921617

Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM.

Fleur van Aar1, Sofie H Mooij, Marianne A B van der Sande, Arjen G C L Speksnijder, Ineke G Stolte, Chris J L M Meijer, Dominique W M Verhagen, Audrey J King, Henry J C de Vries, Maarten F Schim van der Loeff.   

Abstract

OBJECTIVE: Anal and penile high-risk human papillomavirus (HPV) infection is associated with anogenital cancer, which is especially common in HIV-infected MSM. We assessed HPV prevalence and determinants in MSM.
DESIGN: Analysis of baseline data from a prospective cohort study.
METHODS: MSM aged 18 years or older were recruited in Amsterdam, the Netherlands. Participants completed risk-factor questionnaires. HPV DNA was analyzed in anal and penile shaft self-swabs and genotyped using a sensitive PCR and reverse line blot assay (SPF10-PCR-DEIA-LiPA25-system). Multivariable logistic regression analyses were performed to assess determinants of high-risk HPV infection.
RESULTS: MSM (n = 778) were recruited in 2010-2011, of whom 317 (41%) were HIV-infected. Prevalence of anal high-risk HPV infection was 45% in HIV-negative versus 65% in HIV-infected MSM (P <0.001). HPV-16 was the most frequently detected type and was more common in HIV-infected MSM (13% in HIV-negative and 22% in HIV-infected MSM; P = 0.001). Prevalence of penile high-risk HPV infection was 16% in HIV-negative and 32% in HIV-infected MSM (P <0.001). In multivariable analyses, HIV infection remained associated with anal [adjusted odds ratio (aOR) 2.2; 1.8-2.7] and penile (aOR 2.0; 1.4-2.9) high-risk HPV infection. Higher number of lifetime male sex partners was significantly associated with anal and penile high-risk HPV in HIV-negative, but not HIV-infected MSM. Receptive anal intercourse was associated with anal high-risk HPV in HIV-infected MSM.
CONCLUSION: Anal and penile high-risk HPV infections are very common in MSM. HIV infection is a strong and independent determinant for anal and penile high-risk HPV infection. Determinants for HPV infection appear to differ between HIV-negative and HIV-infected MSM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23921617     DOI: 10.1097/01.aids.0000432541.67409.3c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  41 in total

1.  Human Papillomavirus Vaccination and Infection in Young Sexual Minority Men: The P18 Cohort Study.

Authors:  Perry N Halkitis; Pamela Valera; Caleb E LoSchiavo; Stephen E Goldstone; Maria Kanztanou; Anthony J Maiolatesi; Danielle C Ompad; Richard E Greene; Farzana Kapadia
Journal:  AIDS Patient Care STDS       Date:  2019-04       Impact factor: 5.078

2.  [The STIKO now recommends the HPV vaccination for boys too].

Authors:  Stefanie J Klug; Marianne van der Sande; Martin Terhardt; Fred Zepp; Marianne Röbl-Mathieu; Jörg Meerpohl; Miriam Wiese-Posselt; Thomas Harder; Ole Wichmann; Anja Takla
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

3.  Human Immunodeficiency Virus Status Differentially Associated With Genital and Anal Human Papillomavirus Infection Among Chinese Men Who Have Sex With Men: A Cross-Sectional Survey.

Authors:  Han-Zhu Qian; Yifei Hu; James G Carlucci; Lu Yin; Xiangwei Li; Anna R Giuliano; Dongliang Li; Lei Gao; Yiming Shao; Sten H Vermund
Journal:  Sex Transm Dis       Date:  2017-11       Impact factor: 2.830

4.  HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland.

Authors:  C Sadlier; A Lynam; S O'Dea; S Delamere; M Quinlan; S Clarke; O Sheils; C Bergin
Journal:  Hum Vaccin Immunother       Date:  2016-05-06       Impact factor: 3.452

Review 5.  HIV-positive MSM's knowledge of HPV and anal cancer self-sampling: A scoping review.

Authors:  M K L Poon; J P H Wong; A T W Li; M Manuba; A Bisignano; M Owino; M Vahabi
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

6.  Prevalence of Anal High-Risk Human Papillomavirus Infections Among HIV-Positive and HIV-Negative Men Who Have Sex With Men in Nigeria.

Authors:  Rebecca G Nowak; Patti E Gravitt; Xin He; Sosthenes Ketende; Wuese Dauda; Helen Omuh; William A Blattner; Manhattan E Charurat
Journal:  Sex Transm Dis       Date:  2016-04       Impact factor: 2.830

Review 7.  HPV and anal cancer in HIV-infected individuals: a review.

Authors:  Maarten F Schim van der Loeff; Sofie H Mooij; Oliver Richel; Henry J C de Vries; Jan M Prins
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

8.  Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women.

Authors:  Ross D Cranston; Alex Carballo-Diéguez; Holly Gundacker; Barbra A Richardson; Rebecca Giguere; Curtis Dolezal; Aaron Siegel; Ratiya P KunjaraNaAyudhya; Kailazarid Gomez; Jeanna M Piper; Javier R Lama; Ian McGowan
Journal:  Int J STD AIDS       Date:  2018-10-18       Impact factor: 1.359

9.  Uptake of the HPV vaccine among people with and without HIV, cisgender and transgender women and men who have sex with men and with women at two sexual health clinics in Mexico City.

Authors:  Betania Allen-Leigh; Leonor Rivera-Rivera; Elsa Yunes-Díaz; Alejandra Jalil Portillo-Romero; Brandon Brown; Leith León-Maldonado; Galileo Vargas-Guadarrama; Jorge Salmerón; Eduardo Cesar Lazcano-Ponce
Journal:  Hum Vaccin Immunother       Date:  2019-11-01       Impact factor: 3.452

10.  Circumcision to prevent HIV and other sexually transmitted infections in men who have sex with men: a systematic review and meta-analysis of global data.

Authors:  Tanwei Yuan; Thomas Fitzpatrick; Nai-Ying Ko; Yong Cai; Yingqing Chen; Jin Zhao; Linghua Li; Junjie Xu; Jing Gu; Jinghua Li; Chun Hao; Zhengrong Yang; Weiping Cai; Chien-Yu Cheng; Zhenzhou Luo; Kechun Zhang; Guohui Wu; Xiaojun Meng; Andrew E Grulich; Yuantao Hao; Huachun Zou
Journal:  Lancet Glob Health       Date:  2019-04       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.